Cognetivity Neurosciences LtdCanadian Securities Exchange:CGNView on OTCQB
- LAST PRICE0.2900
- TODAY'S CHANGE (%)-0.0100 (-3.3333%)
- Bid / Lots0.2850/ 7
- Ask / Lots0.3100/ 40
- Open / Previous Close0.2950 / 0.3000
- Day Range
- 52 Week Range
- Volume188,600
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CGN |
|---|---|---|
| 09:32 ET | 1000 | 0.295 |
| 10:50 ET | 23500 | 0.3 |
| 11:13 ET | 27000 | 0.3 |
| 11:15 ET | 1000 | 0.3 |
| 12:45 ET | 3000 | 0.3 |
| 01:03 ET | 123000 | 0.28 |
| 02:06 ET | 7000 | 0.29 |
| 02:29 ET | 500 | 0.29 |
| 02:31 ET | 1500 | 0.29 |
May 31, 2023
Cognetivity Neurosciences Announces Collaboration with Alzheimer's Society to Further Expand its AI Algorithms, from 8:56AM ET on Wednesday May 31, 2023 by Newsfile
8:56AM ET on Wednesday May 31, 2023 by Newsfile
May 9, 2023
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cognetivity Neurosciences Ltd | 25.2M | -2.3x | --- |
VentriPoint Diagnostics Ltd | 27.4M | -5.3x | --- |
Scryb Inc | 27.0M | -1.7x | --- |
Cannabix Technologies Inc | 33.1M | -13.6x | --- |
Izotropic Corp | 17.1M | -2.6x | --- |
MyndTec Inc | 15.8M | -9.1x | --- |
Company Information
Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company is engaged in developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments for potentially allowing early diagnosis of dementia. The Company’s ICA uses artificial intelligence and machine learning techniques to detect the earliest signs of cognitive impairment by testing the performance of brain. Its products include CognICA and OptiMind. The CognICA has various applications from providing a measure of cognitive function, to long-term health monitoring, corporate wellness, and personalized brain health. The OptiMind is a wellness app that measures individuals everyday cognitive performance. The Company serves various industries, including healthcare, elder care, enterprise, everyday use, and research. The ICA is available for clinical use in the United States of America, United Kingdom and Europe.
Contact Information
- Headquarters
- 1980-1075 West, Georgia Street,VANCOUVER, BC, Canada V6E 3C9
- Phone
- 604-688-9588
- Fax
- 604-688-9588
Executives
- Chief Executive Officer, Director
- Sina Habibi
- Chief Financial Officer, Chief Operating Officer, Corporate Secretary, Director
- Thomas Sawyer
- Chief Scientific Officer
- Seyed Madhi Khaligh Razavi
- Chief Compliance Officer, Director
- Mark Phillips
- Chief Medical Officer, Director
- Christos Kalafatis
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $25.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 87.0M |
Cognetivity Neurosciences Ltd does not pay a dividend. | |
Beta | 0.10 |
EPS | $-0.13 |
Book Value | $-0.07 |
P/E Ratio | -2.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
